Company News: Merck (MRK) Q3 results beat analysts’ forecasts

Market news

25 October 2016

Company News: Merck (MRK) Q3 results beat analysts’ forecasts

Merck reported Q3 FY 2016 earnings of $1.07 per share (versus $0.96 in Q3 FY 2015), beating analysts' consensus estimate of $0.99.

The company's quarterly revenues amounted to $10.536 bln (+4.6% y/y), beating analysts' consensus estimate of $10.180 bln.

The company also issued guidance for FY 2016, raising EPS to $3.71-3.78 from $3.67-3.77 (versus analysts' consensus estimate of $3.75) and revenue to $39.7-40.2 bln from $39.1-40.1 bln (versus analysts' consensus estimate of $39.69 bln).

MRK rose to $$61.50 (+1.23%) in pre-market trading.

Orders

Wall Street skeptical about the deal between AT & T and Time Warner

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.